Dole Food Co. laying off 172 berry workers in Oxnard
Dole Food Co. reported that it would lay off 172 workers in Oxnard as part of the permanent closure of its Dole Berry subsidiary’s operations in the region. The Westlake Village-based company may be looking to wind down its Tri-Counties operations entirely. It had 600 employees in the Tri-Counties as of 2016, according to Pacific Read More →
California Museum of Art Thousand Oaks looking to expand
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen partnering with Humana to study diseases
Thousand Oaks biotechnology giant Amgen announced a collaboration agreement with Louisville, Ky.-based Humana on Aug. 17 to study conditions like cardiovascular disease, osteoporosis, neurologic disorders, inflammatory diseases and cancer. The two companies currently have six projects underway focusing on improving health care quality and costs with data from Humana’s 13 million members, including wearable technology, Read More →
Mannkind reports net loss for second quarter
Mannkind reported $2.16 million in revenues Aug. 7, for a net loss of around $35.3 million for its second quarter, and announced the launch of a clinical trial for its inhalable insulin product Afrezza in partnership with One Drop. Revenues came primarily from the Westlake Village biotech company’s product sales, with $615,000 from collaborations and Read More →
Sienna stock still soaring after $65 million IPO
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Teledyne reports record sales for second quarter
Thousand Oaks-based tech giant Teledyne reported record sales for its second quarter, ended July 2, reaching $671.1 million and net income of $60.1 million, or $1.66 per diluted share. In addition to growth in all its major product lines — particularly its digital imaging segment, which saw an 89.6 percent increase to $188.5 million — Read More →
Amgen stock drops despite strong earnings
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
